Company intelligence
Aitia
Leader in applying causal Al and Gemini Digital Twins to build the deep biological knowledge that transforms drug R&D
Biotechnology Research
Cambridge, US
90 employees
Founded 2000
1 public signals
About Aitia
Aitia is the leader in leveraging the convergence of patient multiomic and outcome data, high-performance computing, and causal learning and AI to reveal the deeply complex circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. With this new knowledge, which we capture in our Gemini Digital Twins (computational representatives) of human disease, we work with pharmaceutical partners to apply our discoveries to the next generation of breakthrough therapies.
Verified activity
Signals from Aitia
1 published signal